News
Public · Published
Elon Musk Says Eli Lilly Has 'Some Banger Drugs Coming Out' After CEO Dave Ricks Bets Against Vinod Khosla's Big Biotech Skepticism
Elon Musk said Eli Lilly has "some banger drugs coming out" after CEO Dave Ricks replied "I'll take that bet" to investor Vinod Khosla, who doubted big biotech firms would deliver breakthroughs. Neither Musk nor Ricks named specific drugs.
Published:
Updated:
What happened
Elon Musk said Eli Lilly has "some banger drugs coming out" after CEO Dave Ricks replied "I'll take that bet" to investor Vinod Khosla, who doubted big biotech firms would deliver breakthroughs. Neither Musk nor Ricks named specific drugs.
Confirmed
Global impact / market context
Public backing from Musk, a high-profile figure, can draw retail investor attention to Eli Lilly shares and to its drug pipeline, which means the experimental medicines it is developing. A CEO publicly accepting a skeptic's bet signals confidence, but no named drug means investors cannot yet judge the claim.
Analyst inference
The exchange played out on social media X, where biotech enthusiasts discuss trial results. The thread cited Lilly's retatrutide reaching about 28% weight loss in a Phase 3 trial, a weight-loss drug result that can shape investor views on Lilly versus Novo Nordisk and Merck.
Analyst inference
What to watch
- Lilly's retatrutide reached about 28% weight loss in a Phase 3 trial, a late-stage study. Watch whether Lilly releases fuller trial data, which would let investors compare it with rival weight-loss treatments. Confirmed
- Watch whether Ricks or Lilly names the specific drugs behind the "banger" comment, since named treatments would let investors assess revenue potential and the costs of bringing them to market. Proposed
- Watch Lilly, Novo Nordisk and Merck shares for retail-driven swings after Musk's post, since social media attention can move investor positioning before any trial data or regulatory filing confirms the drugs' prospects. Analyst inference
Evidence
- Original source link unavailable